PMID- 31795575
OWN - NLM
STAT- MEDLINE
DCOM- 20191224
LR  - 20200108
IS  - 0253-9624 (Print)
IS  - 0253-9624 (Linking)
VI  - 53
IP  - 12
DP  - 2019 Dec 6
TI  - [Improving immunization strategy and promoting the development of tetanus 
      prevention and control in China].
PG  - 1203-1205
LID - 10.3760/cma.j.issn.0253-9624.2019.12.003 [doi]
AB  - Neonatal tetanus has been basically eliminated in China, but the incidence of 
      non-neonatal tetanus is still high. Tetanus after trauma is the main type of 
      non-neonatal tetanus. The correct application of tetanus toxoid containing 
      vaccine (TTCV) has been neglected in the prevention of tetanus after trauma in 
      China. On May 9, 2019, National Advisory Committee of Experts on Immunization 
      Planning (NIAC) reviewed and approved the first guidelines for the use of TTCV 
      and passive immune preparation after trauma, which clarified the basic process of 
      treatment of tetanus after trauma, as well as the pointer to the use of TTCV and 
      passive immune preparation after trauma. The main measure to prevent tetanus 
      after trauma is to use TTCV for active immunization, and to use passive immune 
      preparation for those without TTCV immune history. Through the construction of 
      the top-down control and prevention system of tetanus, the change of the concept 
      of tetanus immunoprophylaxis of medical staff is promoted. Active immunization is 
      the main measure, but passive immunization is an added measure for the prevention 
      of tetanus after trauma, which is of great significance to reverse the mistake of 
      prevention of tetanus in China.
FAU - Wang, C L
AU  - Wang CL
AD  - Emergency Depratment/Trauma Center, Peking University People's Hospital, Beijing 
      100044, China.
LA  - chi
PT  - Journal Article
PL  - China
TA  - Zhonghua Yu Fang Yi Xue Za Zhi
JT  - Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]
JID - 7904962
RN  - 0 (Tetanus Toxoid)
SB  - IM
MH  - China
MH  - Humans
MH  - *Immunization
MH  - *Practice Guidelines as Topic
MH  - Tetanus/*prevention & control
MH  - Tetanus Toxoid/*administration & dosage
MH  - Vaccination
OTO - NOTNLM
OT  - Tetanus
OT  - Tetanus immunoglobulin
OT  - Tetanus toxoid containing vaccine
OT  - Vaccination
EDAT- 2019/12/05 06:00
MHDA- 2019/12/25 06:00
CRDT- 2019/12/05 06:00
PHST- 2019/12/05 06:00 [entrez]
PHST- 2019/12/05 06:00 [pubmed]
PHST- 2019/12/25 06:00 [medline]
AID - 10.3760/cma.j.issn.0253-9624.2019.12.003 [doi]
PST - ppublish
SO  - Zhonghua Yu Fang Yi Xue Za Zhi. 2019 Dec 6;53(12):1203-1205. doi: 
      10.3760/cma.j.issn.0253-9624.2019.12.003.